Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Sun

Showing results (1291-1300 of 1,349) with videos related to

Pageof 135
Sort By:
Applied Optics|June 20, 1997
Optical properties of deep ice at the South Pole: absorptionP Askebjer, S W Barwick, L Bergström, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|January 3, 2023
[Status of fungal sepsis among preterm infants in 25 neonatal intensive care units of tertiary hospitals in China]X C Cao, S Y Jiang, S J Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
Zhonghua Yi Xue Za Zhi|May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]Z F Jiang, F R Xu, J Fan, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Zhonghua Yi Xue Za Zhi|April 26, 2018
[Dynamic investigation of nutritional risk in patients with malignant tumor during hospitalization]M W Zhu, J M Wei, W Chen, et al.
Physical Review Letters|May 30, 2020
Positive-Parity Linear-Chain Molecular Band in ^{16}CY Liu, Y L Ye, J L Lou, et al.
Zhonghua Nei Ke Za Zhi|January 25, 2025
[Expert consensus on visualized tele-round and quality control management based on the improvement of clinical practice ability]M G Yin, X T Wang, R Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerC E Geyer, J E Garber, R D Gelber, et al.
Pageof 135

Showing results (1291-1300 of 1,349) with videos related to

Sort By:
Pageof 135
Applied Optics|June 20, 1997
Optical properties of deep ice at the South Pole: absorptionP Askebjer, S W Barwick, L Bergström, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|January 3, 2023
[Status of fungal sepsis among preterm infants in 25 neonatal intensive care units of tertiary hospitals in China]X C Cao, S Y Jiang, S J Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
Zhonghua Yi Xue Za Zhi|May 11, 2018
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer]Z F Jiang, F R Xu, J Fan, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Zhonghua Yi Xue Za Zhi|April 26, 2018
[Dynamic investigation of nutritional risk in patients with malignant tumor during hospitalization]M W Zhu, J M Wei, W Chen, et al.
Physical Review Letters|May 30, 2020
Positive-Parity Linear-Chain Molecular Band in ^{16}CY Liu, Y L Ye, J L Lou, et al.
Zhonghua Nei Ke Za Zhi|January 25, 2025
[Expert consensus on visualized tele-round and quality control management based on the improvement of clinical practice ability]M G Yin, X T Wang, R Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerC E Geyer, J E Garber, R D Gelber, et al.
Pageof 135